| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.59 | 0.03 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.32 | 0.03 |